Safety of Intranodal ECI-006 in Melanoma Patients
Phase 1
Terminated
- Conditions
- Melanoma
- Interventions
- Biological: ECI-006
- First Posted Date
- 2018-01-09
- Last Posted Date
- 2021-06-21
- Lead Sponsor
- eTheRNA immunotherapies
- Target Recruit Count
- 21
- Registration Number
- NCT03394937
- Locations
- 🇧🇪
032-004_GZA Sint-Augustinus, Antwerpen, Belgium
🇧🇪Site 032-007_AZ Sint Maarten, Mechelen, Belgium
🇧🇪032-002_UCL Brussels, Brussel, Belgium
© Copyright 2025. All Rights Reserved by MedPath